Showing 5,321 - 5,340 results of 63,539 for search '(( 50 ((mean decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 2 e decrease ))', query time: 0.93s Refine Results
  1. 5321
  2. 5322
  3. 5323
  4. 5324
  5. 5325
  6. 5326

    Supplementary Material for: An early phase 2 double-blind, placebo-controlled study of E6011, a novel anti-fractalkine antibody, in patients with Crohn’s disease by figshare admin karger (2628495)

    Published 2025
    “…Methods: In this early phase 2, double-blind, placebo-controlled study, we examined the efficacy and safety of E6011 in patients with moderate to severe active CD in a 12-week, double-blind period and the long-term efficacy and safety of E6011 in a subsequent open-label period for a maximum of 52 weeks. …”
  7. 5327
  8. 5328

    Mcl-1 degradation is slowed by a T163E mutation (but not T163A) in transfected CHO cells. by Shanna K. Nifoussi (128297)

    Published 2012
    “…In Panel B, the decline in Mcl-1 expression at 3 hours in 2 independent experiments ranged from 53–66% with WT-Mcl-1, 25–54% with Mcl-1-S162A, and 25–50% with Mcl-1-T163A. …”
  9. 5329
  10. 5330
  11. 5331
  12. 5332
  13. 5333
  14. 5334
  15. 5335
  16. 5336
  17. 5337
  18. 5338
  19. 5339

    Pharmacological and toxicological evaluation of two anti-asthmatic polyherbal formulations by UZMA SALEEM (10364699)

    Published 2021
    “…<div><p>Abstract The study aim was to evaluate the toxic potential of two polyherbal formulation i.e. “ PH 1 & PH 2” and scientific validation of their anti-asthmatic use. …”
  20. 5340